C. Barrie
Director/Miembro de la Junta en NORAM LITHIUM CORP. .
Fortuna: 167 826 $ al 31/05/2024
Perfil
C.
Tucker Barrie is currently a Director at Noram Lithium Corp.
He previously held positions as President, Chief Executive Officer & Director at Windfall Geotek, Inc., President & Chief Executive Officer at Noram Lithium Corp., and Vice President-Corporate Development at Mindesta, Inc. Barrie has a graduate degree from The University of Texas at Austin and a doctorate degree from the University of Toronto.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
NORAM LITHIUM CORP
2.27% | 14/06/2024 | 2 022 000 ( 2.27% ) | 167 826 $ | 31/05/2024 |
Cargos activos de C. Barrie
Empresas | Cargo | Inicio |
---|---|---|
NORAM LITHIUM CORP. | Director/Miembro de la Junta | 05/04/2024 |
Antiguos cargos conocidos de C. Barrie.
Empresas | Cargo | Fin |
---|---|---|
WINDFALL GEOTEK INC. | Director Ejecutivo | 15/06/2016 |
NORAM LITHIUM CORP. | Director Ejecutivo | - |
Mindesta, Inc.
Mindesta, Inc. Pharmaceuticals: GenericHealth Technology Mindesta, Inc. provides drug delivery systems technology services through its wholly owned subsidiary CTT Pharmaceuticals, Inc. CTT Pharma is a developmental stage company which has had limited operations to date and it specializes in drug delivery systems technology within the pharmaceutical industry. Mindesta was founded on November 6, 1996 and is headquartered in Ottawa, Canada. | Corporate Officer/Principal | - |
Formación de C. Barrie.
University of Toronto | Doctorate Degree |
The University of Texas at Austin | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
WINDFALL GEOTEK INC. | Non-Energy Minerals |
NORAM LITHIUM CORP. | Non-Energy Minerals |
Empresas privadas | 1 |
---|---|
Mindesta, Inc.
Mindesta, Inc. Pharmaceuticals: GenericHealth Technology Mindesta, Inc. provides drug delivery systems technology services through its wholly owned subsidiary CTT Pharmaceuticals, Inc. CTT Pharma is a developmental stage company which has had limited operations to date and it specializes in drug delivery systems technology within the pharmaceutical industry. Mindesta was founded on November 6, 1996 and is headquartered in Ottawa, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- C. Barrie